Status: current, Defined. Date: 31-Jul 2020. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4432521000168117 | cannabidiol 72.5 mg / 1 mL + delta-9-tetrahydrocannabinol 1 mg / 1 mL oral liquid, 30 mL (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4432531000168119 | delta-9-tetrahydrocannabinol 1 mg/mL + cannabidiol 72.5 mg/mL oral liquid, 30 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
delta-9-tetrahydrocannabinol 1 mg/mL + cannabidiol 72.5 mg/mL oral liquid, 30 mL | Is a | medicinal product pack | true | Inferred relationship | Some | ||
delta-9-tetrahydrocannabinol 1 mg/mL + cannabidiol 72.5 mg/mL oral liquid, 30 mL | has MPUU | delta-9-tetrahydrocannabinol 1 mg/mL + cannabidiol 72.5 mg/mL oral liquid | true | Inferred relationship | Some | 1201922821 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Xanadolen Tincture CBD 9:1 THC oral liquid, 30 mL | Is a | True | delta-9-tetrahydrocannabinol 1 mg/mL + cannabidiol 72.5 mg/mL oral liquid, 30 mL | Inferred relationship | Some |
Reference Sets
Schedule 8 medications reference set
Medicinal product pack reference set